The Influence of a HAART regimen on the expression of HIV-associated Kaposi sarcoma

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):111. doi: 10.1097/QAI.0b013e31816d9d2b.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Male
  • Recurrence
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Sarcoma, Kaposi / diagnosis*

Substances

  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors